Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report

Felix Firyanto Widjaja, Kemal Fariz Kalista, Juferdy Kurniawan


Background: nowadays, radiofrequency ablation (RFA) is applied widely as an alternative therapy of resection in patient with hepatocellular carcinoma (HCC). Moreover, in single nodule with size of less than 2 cm, RFA can be the primary treatment. Although resection is the main treatment and one of the curative treatments in nodule meeting Milan criteria, it needs consideritation of the surgery risk stratification. This report was aimed to search evidence of RFA compared with RFA in term of survival in patient with HCC single nodule size of more than 5 cm. Methods: the searching was done using PubMed, Scopus, Web of Science, dan CINAHL from EBSCO with keyword of “hepatocellular carcinoma”, “single nodule”, “radiofrequency ablation”, “resection”, and “survival”. The limitation of the article was English with clinical question of “In patient with HCC single nodule size of more than 5cm, was RFA more superior in resection in term of survival?”. Results: there were three articles with retrospective study. One of the article combined RFA and percutaneous ethanol injection in the analysis, meanwhile another article combined RFA and transarterial chemoembolization. These articles showed conflicting data that showed absolute risk reduction of 33% till absolute risk increment of 60.6%. Conclusion: all studies used RFA as the alternative of resection when the the tumor was irresectable which means the severity is higher in RFA group. Hence, we can not solely conclude that RFA resulted in worse survival.


hepatocellular carcinoma; radiofrequency ablation; resection


Omata M, Cheng A-L, Kokudo N, et al. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317-70.

Indonesian Liver Cancer Study Group. Konsensus Nasional Penatalaksanaan Karsinoma Sel Hati. In: Hasan I, Loho IM, eds. Jakarta: Perhimpunan Peneliti Hati Indonesia; 2017.

Dufour JF, Greten TF, Raymond E, et al. Clinical practice guidelines EASL – EORTC clinical practice guidelines: Management of hepatocellular carcinoma European Organisation for Research and Treatment of Cancer. J Hepatol. 2012;56(4):908-43.

Wong LL, Hernandez BY, Shvetsov YB, Kawano Y, Tang ZY, Ji JF. Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries. World J Hepatol. 2016;8(31):1327-35.

Ogihara M, Wong LL, Machi J. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: Long-term outcomes. Hpb. 2005;7(3):214-21.

Ruzzenente A, Guglielmi A, Sandri M, et al. Surgical resection versus local ablation for HCC on cirrhosis: Results from a propensity case-matched study. J Gastrointest Surg. 2012;16(2):301-11.

Jung YK, Jung CH, Seo YS, et al. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A. J Gastroenterol Hepatol. 2016;31(2):467-74.

Ho EY, Cozen ML, Shen H, et al. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma. Hpb. 2014;16(8):758-67.

Changyong E, Wang D, Yu Y, Liu H, Ren H, Jiang T. Efficacy comparison of radiofrequency ablation and hepatic resection for hepatocellular carcinoma: A meta-analysis. J Cancer Res Ther. 2017;13(4):625.

Tanaka M, Ando E, Simose S, et al. Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma. Hepatol Res. 2014;44(2):194-200.

Pan T, Mu L-W, Wu C, et al. Comparison of combined transcatheter arterial chemoembolization and CT-guided radiofrequency ablation with surgical resection in patients with hepatocellular carcinoma within the up-to-seven Criteria: a multicenter case-matched study. J Cancer. 2017;8(17):3506-13.

Hocquelet A, Seror O, Blanc J-F, et al. Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation. Oncotarget. 2017;8(19):32190-200.

Zhong J-H, Xiang B-D, Gong W-F, et al. Comparison of long-term survival of patients with BCLC Stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One. 2013;8(7):e68193.

Parisi A, Desiderio J, Trastulli S, et al. Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12(3):270-7.

Chie W-C, Yu F, Li M, et al. Quality of life changes in patients undergoing treatment for hepatocellular carcinoma. Qual Life Res. 2015;24(10):2499-506.

Full Text: PDF


  • There are currently no refbacks.

Copyright (c) 2019 Acta Medica Indonesiana